PSNLNasdaqServices-Medical LaboratoriesFiscal year ends December 31

Personalis, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026

$15.88+0.23 (+1.47%)

Close on Oct 19, 2026

Market cap: $1.67B
P/E (TTM): –
Dividend yield: –

Personalis, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31
Revenue	70	85	73	65	85	79	65	38	9.39
Cost of Revenue	54	58	55	52	54	59	43	26	12
Gross Profit	16	27	18	13	32	20	22	12	-2.34
Research & Development	50	49	65	65	49	29	22	14	9.92
Selling, General & Admin	54	46	50	64	48	34	22	11	9.90
Total Costs & Expenses	158	153	183	181	151	121	88	52	32
Operating Income	-88	-68	-110	-116	-65	-42	-22	-14	-22
Interest Expense	0.21	0.02	0.11	0.20	0.18	0.00	1.13	1.89	1.30
Interest & Investment Income	7.16	5.51	5.90	2.40	0.37	0.95	1.62	0.29	0.10
Other Non-Operating Income	-0.14	-18	-4.07	0.06	-0.04	-0.02	-1.44	0.15	-0.23
Merger & Restructuring Charges	–	–	8.08	–	–	–	–	–	–
Gain (Loss) on Investments	–	–	–	–	–	0	0	–	–
Pretax Income	-81	-81	-108	-113	-65	-41	-25	-20	-24
Income Tax Expense	0.02	0.02	0.08	0.04	0.01	0.06	0.01	0.01	0.01
Net Income incl. Noncontrolling Interests	-81	-81	-108	-113	-65	-41	-25	-20	-24
Net Income	-81	-81	-108	-113	-65	-41	-25	-20	-24
Net Income to Common	–	–	–	–	–	-41	-25	-20	-24
EPS (Basic)(per share)	-0.91	-1.37	-2.25	-2.48	-1.49	-1.20	-1.39	-6.49	-7.78
EPS (Diluted)(per share)	-0.91	-1.37	-2.25	-2.48	-1.49	-1.20	-1.39	-6.49	-7.78
Shares Outstanding (Basic, Weighted)(shares)	89	59	48	46	44	34	18	3.06	3.04
Shares Outstanding (Diluted, Weighted)(shares)	89	59	48	46	44	34	18	3.06	3.03
EBITDA	-78	-57	-99	-107	-59	-36	-18	-11	-21

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 12.7%
Operating margin: -164.1%
Net margin: -153.8%
Return on equity, FY2025: -35.0%

Financial strength

Current ratio: 5.28
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 202.6%

Valuation

P/E ratio: –
Price to sales: 24.03
Price to book: 7.12
Dividend yield: –